[Clinical efficacy of alprostan in combination with "Bioptron-II" rays and iruxol-miramistin in the treatment of the diabetic foot complicated by atherosclerosis].

Experience of clinical treatment of 9 patients with diabetes mellitus and diabetic angiopathy using alprostan in combination with rays "Bioptron-II" and iruxol-miramistinum in conditions of polyclinic was summarized. Antidiabetic preparations, mainly insulin, were administered to all patients together with abovementioned treatment. Optimal scheme of treatment constitutes daily slow (no less than 6 h) dropper intravenous infusion of alprostan in 0.

[Endoscopic electrocoagulation and controlled pharmacological hypotension in the treatment of acute gastrointestinal hemorrhage].

The experience with the treatment of 602 patients with gastrointestinal bleeding before the introduction of endoscopy, and 805--with the use of endoscopy is summarized. At investigation, it was established that in 587 (72.9%) patients, the bleeding stopped, in 180 (27.